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Abstract: Tryptanthrin, a kind of indole quinazoline alkaloid, has been shown to exhibit 
anti-microbial, anti-inflammation and anti-tumor effects both in vivo and in vitro. However, 
its  biological  activity  on  human  chronic  myeloid  leukemia  cell  line  K562  is  not  fully 
understood.  In  the  present  study,  we  investigated  the  proliferation-attenuating  and 
apoptosis-inducing effects of tryptanthrin on leukemia K562 cells in vitro and explored the 
underlying mechanisms. The results showed that tryptanthrin could significantly inhibit 
K562 cells proliferation in a time- and dose-dependent manner as evidenced by MTT assay 
and flow cytometry analysis. We also observed pyknosis, chromatin margination and the 
formation of apoptotic bodies in the presence of tryptanthrin under the electron microscope. 
Nuclei fragmentation and condensation by Hoechst 33258 staining were detected as well. 
The amount of apoptotic cells significantly increased whereas the mitochondrial membrane 
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potential decreased dramatically after tryptanthrin exposure. K562 cells in the tryptanthrin 
treated  group  exhibited  an  increase  in  cytosol  cyt-c,  Bax  and  activated  caspase-3 
expression while a decrease in Bcl-2, mito cyt-c and pro-caspase-3 contents. However, the 
changes of pro-caspase-3 and activated caspase-3 could be abolished by a pan-caspase 
inhibitor ZVAD-FMK. These results suggest that tryptanthrin has proliferation-attenuating 
and  apoptosis-inducing  effects  on  K562  cells.  The  underlying  mechanism  is  probably 
attributed to the reduction in mitochondria membrane potential, the release of mito cyt-c 
and pro-caspase-3 activation. 
Keywords: tryptanthrin; chronic myeloid leukemia; proliferation; apoptosis; K562 cells 
 
1. Introduction 
Chronic myeloid leukemia (CML) is initiated by the aberrant pluripotent hematopoietic stem cell 
(HSC) growth and apoptosis characterized by accumulation of immature granulocytes in the peripheral 
blood and bone marrow. The highly proliferative feature of leukemia cells distinguishes them from 
most normal cells. Therefore, inhibiting HSC proliferation might promote leukemia cell apoptosis and 
cell cycle arrest, which is clinically beneficial in the therapeutic strategy of CML [1]. 
The  disturbance  of  balance  between  HSC  proliferation  and  apoptosis  plays  a  critical  role  in 
the pathogenesis  of  leukemia  and  apoptosis-inducing  mechanism  and  is  clinically  used  to  treat 
leukemia [2,3]. Imatinib mesylate, an orally administrated tyrosine kinase inhibitor is recommended as 
the first-line drug for bcr-abl fusion gene positive CML patients. Imatinib mesylate competitively 
inhibits ATP binding to bcr-abl tyrosine kinase and promotes CML cells apoptosis. Apoptosis, known 
as programmed cell death (PCD), is essential for normal development and cell homeostasis and it 
participates  in  many  pathological  processes  [4].  It  is  morphologically  characterized  by  chromatin 
margination and the formation of apoptotic bodies [5]. Recently, mitochondria depolarization has been 
recognized as an early event in the process of apoptosis [6,7]. Decreased mitochondria membrane 
potential inhibits ATP generation, results in oxidative stress and promotes mitochondria dysfunction. 
Mitochondrial cyt-c (mito cyt-c) leakage into the cytoplasm would activate pro-caspase and caspase 
cascade, especially the caspase-3, which facilitates cell apoptosis in return [8]. 
Although a number of chemotherapy regimens can induce leukemia cell apoptosis and increase the 
overall survival time, the recurrence of leukemia due to micro-residential disease (MRD) remains a 
common  problem.  Meanwhile,  the  clinically  used  chemotherapeutics  (such  as  cyclophosphamide, 
CTX) have severe and inevitable adverse effects. Therefore, it is important and urgent to look for an 
effective  treatment  for  MRD  and  the  naturally  synthetic  compounds  seems  to  offer  more  clinical 
benefits  in  the  treatment  and  prevention  of  leukemia  [9].  Tryptanthrin  is  a  naturally  occurring 
substance  firstly  isolated  by  Honda  et  al.  from  the  indigo  plant  Polygonum  tinctorium,  and  they 
reported that tryptanthrin has a broad spectrum of biological functions, such as anti-inflammatory, 
anti-fungal and  anti-bacterial effects  [10–12].  Increasing evidence  showed tryptanthrin has a wide 
range of downstream targets that regulate tumor-associated cell processes including cell growth, cell 
cycle  progression  and  survival.  Previous  studies  have  demonstrated  that  tryptanthrin  exhibited Int. J. Mol. Sci. 2011, 12                         
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anti-tumor  effects  on  various  kinds  of  solid  tumors  and  it  is  suggested  that  tryptanthrin  inhibits 
multiple drug resistance to chemotherapies and reverses doxorubicin resistance during breast cancer 
therapy  [13].  Meanwhile,  tryptanthrin  is  non-toxic  and  free  of  adverse  effects  on  various  animal 
models using different models of administration [10,12]. Thus it provides many clinical benefits during 
cancer therapy. However, its therapeutic effect on human CML cells has not been fully understood and 
the underlying mechanisms are beyond dispute.   
In  the  present  study,  we  explored  whether  tryptanthrin  has  proliferative-attenuating  and 
apoptosis-inducing  effects  on  human  CML  cells.  We  show  that  tryptanthrin  inhibits  mitochondria 
membrane potential in the human CML cell line K562, accompanied by cell cycle arrest, caspases 
activation, apoptosis induction and proliferation inhibition.   
2. Materials and Methods 
2.1. Reagents 
Medicine:  tryptanthrin  (Batch  No.  20061211;  Figure  1),  6,12-dihydro-6,12-dioxoindolo-(2,1-b)- 
quinazoline, was provided by College of Life Science of Northwest University (Shaanxi province, 
China), with purity over 99.7%. Tryptanthrin was dissolved in dimethyl sulfoxide (DMSO) and diluted 
with culture medium.   
Figure 1. Chemical structure of tryptanthrin. 
 
Materials:  RPMI  medium  and  fetal  bovine  serums  (FBS)  were  purchased  from  Gibco.  MTT 
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl  tetrazolium  bromide],  Hoechst  33258  and  Rhodamine 
123 fluorescent dye were from Sigma. Annexin-V-FITC and pyrimidine of iodinate (PI) were from Bio 
Vision Inc. RIPA Lysis buffer was from Runde Biotech Co. Mouse anti-human β-actin monoclonal IgG 
was from Sigma. Rabbit anti-human Bcl-2, Bax, cyt-c and caspase-3 monoclonal antibodies and the 
respective HRP-labeled secondary antibodies were products from Santa. ZVAD-FMK was purchased 
from Biomol International LP. CTX was obtained from the Institute of Pharmacy, Xijing Hospital, 
Fourth Military Medical University. 
2.2. Cell Culture and Treatment 
K562  human  CML  cells  (bcr-abl  fusion  gene  positive)  were  provided  by  Laboratory  Animal 
Research Center of the Fourth Military Medical University (Shaanxi province, China). Cells were 
cultured in RPMI 1640 medium supplemented with 10% FBS, penicillin (100 U/mL) and streptomycin 
(100 μg/mL) in an atmosphere with 5% CO2 at 37 °C . In all experiments, exponentially growing cells 
were used. Int. J. Mol. Sci. 2011, 12                         
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2.3. MTT Assay 
Cell proliferation was assessed using the MTT assay as previously described. Briefly, 5 ×  10
3 cells 
were incubated in 96-well plates in the presence of 0, 0.39, 0.78, 1.56, 3.12, 6.25, 12.5 and 25 μg/mL 
tryptanthrin for 24 h and 48 h in a final volume of 200 μL. At the end of the treatment, 20 μL MTT   
(5 mg/mL dissolved in PBS) was added to each well and incubated for an additional 4 h at 37 °C . The 
purple-blue  MTT  formazan  precipitate  was  dissolved  in  100  μL  of  DMSO.  The  activity  of  the 
mitochondria, reflecting cellular growth and viability, was evaluated by measuring the optical density 
at 570 nm. The cell survival rate was calculated as Atreatment group/Acontrol group ×  100%. 
2.4. Hoechst 33258 Fluorescent Staining 
K562 cells from exponentially growing cultures were seeded in 24-well culture plates. The cells 
received 0 (control), 6.25, 12.5 and 25 μg/mL tryptanthrin or vehicle (0.5% DMSO) for 48 h. To verify 
the apoptosis-inducing effect of tryptanthrin, CTX (0.5 μg/mL) was selected as a positive control. 
K562  cells  were  incubated  with  CTX  for  48  h  as  well.  The  cells  were  then  washed  in  ice-cold 
phosphate-buffered saline (PBS), and fixed in a solution of methanol-acetic acid (3:1, v/v) for 15 min 
at 4 ° C. To identify the apoptotic K562 cells, they were stained with Hoechst 33258 (5 μg/mL in PBS) 
for 5 min at room temperature. The nuclei structure of the cells was examined by Olympus fluorescence 
microscopy with an excitation wavelength of 340 nm and an emission wavelength of 460 nm. Five 
fields were randomly selected and the apoptotic cells were observed at 200×  magnification. 
2.5. Transmission Electron Microscopy 
K562 cells were incubated with tryptanthrin and CTX under the same conditions as previously 
described. The cells were collected and cell pellets were fixed with 2% glutaraldehyde in 0.1% sodium 
cacodylate buffer, pH 7.4 for 12 h at 4 °C . Fixation was followed by 3–5 min washes with 0.1% 
sodium  cacodylate  buffer,  pH  7.4.  Cells  were  post-fixed  with  a  solution  containing  1%  osmium 
tetroxide  and  2%  K4Fe,  stained  with  1%  uranyl  acetate,  and  pelleted  in  2%  agar.  Pellets  were 
dehydrated in graded ethanol solution and embedded in spur resin. Ultra thin (60 nm) sections were cut 
on a Reichert Ultra cut microtome, collected on Rhodanimu 400-mesh grids, post-stained with uranyi 
acetate and lead citrate, and washed with water. The sections were examined in transmission election 
microscope (JEM-2000EX). 
2.6. Annexin-V/PI Staining, Apoptosis and Cell Cycle Determination by Flow Cytometry 
Cells in each group were collected and diluted to the concentration of 1.0 ×  10
6/mL. The cells were 
washed  twice  and  suspended  in  200  μL  PBS.  After  that,  cells  were  incubated  with  10  μL 
Annexin-V-FITC and 5 μL PI for 30 min at 4 °C . The cells undergoing apoptosis were detected by 
FCM (Beckman Coulter, USA). For the detection of cell cycle, cells were incubated with the solution 
containing RNase and PI for 30 min. At least 10
4 cells were analyzed for each determination. The 
percentages of cells in G0/G1, S and G2/M cell cycle phases were calculated by the Modfit 3.0 program 
(Verity Software House). Int. J. Mol. Sci. 2011, 12                         
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2.7. Measurement of Mitochondrial Membrane Potential (∆ψm) 
Since  the  evidence  that  cells  undergoing  apoptosis  exhibit  reduced  mitochondrial  membrane 
potential (MMP), MMPs were measured to reflect the amount of apoptotic cells. In brief, cells were 
collected and washed twice in PBS and stained with the fluorochrome Rhodamine 123 (5 mg/L) for   
1 h at 37 ° C. After that, cells were centrifuged and washed twice in ice-cold PBS, resuspended in PBS 
and analyzed by FCM. 
2.8. Assay of Bcl-2, Bax, Cyt-c, Procaspase-3 and Caspase-3 
After exposed to 6.25, 12.5 and 25 μg/mL tryptanthrin for 48 h, respectively, cells were collected 
and washed in ice-cold PBS, and lysed in RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl,   
1% NP-40, 0.1% SDS,  1 mM PMSF) for extraction of total protein. We used immunoblotting to 
demonstrate cleavage of pro-caspase-3 to its catalytically active subunits (p20 and p17) as induced by 
mitochondrial cyt-c leakage. To investigate whether tryptanthrin-induced K562 cells apoptosis was 
caspase-dependent,  ZVAD-FMK  (a  pan-caspase  inhibitor)  at  the  concentration  of  20  μmol/L  was 
added into the culture medium before tryptanthrin exposure in another group. After centrifugation for 
10 min at 12,000 g, the supernatants were collected and the total proteins were quantified with the 
Bradford  assay  Kit  (Beyotime  biotechnology,  China).  Equal  amount  of  protein  was  separated  by 
SDS-PAGE and transferred to nitrocellulose membranes at 400 mA for 1 h. Membranes were stained 
with 0.5% Ponceau in 1% acetic acid for confirmation. Blots were blocked for 2 h in TBST (10 mM 
Tris-HCl,  pH  7.4,  150  Mm  NaCl,  0.05%  Tween-20)  containing  5%  fat-free  dried  milk  and  then 
incubated with the primary antibodies (Rabit anti-Bcl-2, Bax, caspase-3 IgG, respectively) for 12 h and 
then incubated with respective HRP-labeled secondary antibodies. Signals were detected using the 
enhanced chemiluminescence system (Minipore).   
To detect cyt-c in mitochondrial and cytosolic fractions during tryptanthrin treatment, mitochondria 
was isolated as previously described [14]. Briefly, K562 cells were treated as above and converted to 
spheroplasts by zymolyase treatments (ICN). Spheroplasts were disrupted by an osmotic shock and a 
hand-potter homogenization to  preserve the outer mitochondrial membrane, and the  mitochondrial 
fraction was recovered after a series of differential centrifugation. The supernatant was collected and 
removed  to  determine  cyt-c  in  cytoplasma.  Where  indicated,  mitochondria  were  incubated  in  the 
presence of 0.1% Triton X-100 for 15 min at 4 °C  and centrifuged for 15 min at 10,500 g and the pellet 
was treated by SDS-PAGE and Western blot analysis. 
2.9. Statistical Analysis 
Clampﬁt software and ORIGIN6.1 software were used to analyze the data. Values are expressed as 
mean ±  SD. One-way analysis of variance was employed to determine the statistical signiﬁcance of the 
different groups. Signiﬁcance level was set at P < 0.05. Int. J. Mol. Sci. 2011, 12                         
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3. Results 
3.1. The Growth Suppression Effect of Tryptanthrin on K562 Cells 
As shown in Figure 2, we observed that tryptanthrin suppressed K562 cell growth using MTT 
staining.  The  cell  survival  rates  decreased  in  parallel  with  elevating  tryptanthrin  concentrations. 
Meanwhile, the cell survival rate in the 48 h group was lower than that in the 24 h group under the 
same tryptanthrin concentration. Tryptanthrin exhibited a growth suppression effect on K562 cells in a 
time- and dose-dependent manner with a 50% decrease in cell proliferation at the concentration (IC50) 
of 8.8 μg/mL after 48 h treatment.   
Figure 2. Effect of tryptanthrin on the survival rate of K562 cells. Cells were treated with 
various  concentrations  of  tryptanthrin  for  24  h  and  48  h.  The  cell  survival  rate  was 
determined by MTT assay. Each data point is the mean of three replicates; bars represent 
the standard deviation. 
 
3.2. Determination of Apoptotic K562 Cells by Hoechst 33258 Staining 
Stained with Hoechst 33258, the K562 cells in the control and 0.5% DMSO groups exhibited small 
and round normal nuclei (Figure 3A,B). In contrast, cells treated with CTX showed signs of apoptosis, 
including  highly  condensed  and  fragmented  nuclei  (Figure  3C).  Meanwhile,  cells  incubated  with 
tryptanthrin at the concentration of 6.25, 12.5 and 25 μg/mL for 48 h also exhibited similar apoptotic 
signs (Figure 3C–F). The amount of cells undergoing apoptosis in each randomly selected field increased 
with the content of tryptanthrin and CTX induced more apoptotic cells than 25 μg/mL tryptanthrin. 
3.3. K562 Cells Ultra Structure 
We observed cell swelling, rarefaction and membrane damage in K562 cells after tryptanthrin and 
CTX treatment. Dilation of the endoplasmic reticulum was also observed (not shown in Figure 4). 
Compared with the control and 0.5% DMSO group, nuclei in the tryptanthrin and CTX treated 
group manifested apoptotic changes, including pyknosis, chromatin margination and the formation of 
apoptotic bodies (Figure 4C–F). No apoptotic cells were observed in the control and 0.5% DMSO 
groups (Figure 4A,B). Int. J. Mol. Sci. 2011, 12                         
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Figure  3.  Fluorescent  staining  of  nuclei  in  tryptanthrin-treated  K562  cells  by  Hoechst 
33258. Cells were incubated in the medium without tryptanthrin (A) or with 0.5% DMSO 
(B),  CTX  (C)  and  with  6.25,  12.5,  25  μg/mL  tryptanthrin  (D,  E  and  F)  for  48  h, 
respectively. Fragmented or condensed nuclei could be observed at 200×  magnification in 
the tryptanthrin-treated group as indicated by the arrows. 
 
Figure  4.  Transmission  electron  micrographs  of  K562  cells  treated  with  different 
concentrations of tryptanthrin. No abnormal changes were observed in the control (A) and 
0.5% DMSO (B) groups. Pyknosis, chromatin margination and the formation of apoptotic 
bodies (white arrows) were clearly observed in the presence of CTX (C) and tryptanthrin at 
the concentrations of 6.25 (D), 12.5 (E) and 25 (F) μg/mL, respectively. 
 
3.4. Tryptanthrin-Induced K562 Cell Apoptosis and FCM Analysis 
K562 cells cultured with trytanthrin were analyzed for apoptosis by Annexin V and PI (Annexin 
V/PI) dual staining. Annexin V/PI staining in the control group showed a large viable cell population Int. J. Mol. Sci. 2011, 12                         
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(marked as PI−AV−) and a small amount of early apoptotic (PI−AV+), late apoptotic (PI+AV+), and 
dead cells (PI+AV−). Tryptanthrin at the concentrations of 6.25, 12.5 and 25 μg/mL resulted in a strong 
shift from viable cells to early and late apoptotic cell population with little change in the dead cell 
population.  FCM  analysis  showed  tryptanthrin  induced  K562  cells  apoptosis  in  a  dose-dependent 
manner. About 21.9% ±  2.3%, 33.4% ±  3.6% and 52.2% ±  4.7% PI+AV+ cells were detected in the 
6.25, 12.5 and 25 μg/mL tryptanthrin groups while that proportions were 0.2% ±  0.01%, 0.6% ±  0.01% 
and 73.0% ±  6.7% in the control group, 0.5% DMSO and CTX group, respectively. There was a 
significance difference in the amount of apoptotic cells in the tryptanthrin-treated groups compared 
with the control group. (Figure 5, data not shown). 
Figure 5. Tryptanthrin caused strong K562 cells apoptosis. Representative FCM analysis 
scattergrams of Annexin V/PI stained control, 0.5% DMSO and treatment with CTX and 
6.25, 12.5 and 25 μg/mL tryptanthrin for 48 h cells showed four different cell populations 
marked  as:  live  cell  population  (PI−AV−),  early  apoptosis  (PI−AV+),  late  apoptosis 
(PI+AV+) and dead cells (PI+AV−). Cells treated with no tryptanthrin (A), 0.5% DMSO (B), 
CTX (C) and 6.25, 12.5 and 25μg/mL tryptanthrin, respectively (D, E and F). 
 
3.5. Changes in Cell Cycle Progression 
To further understand the mechanisms of tryptanthrin-induced K562 cell apoptosis, we analyzed the 
cell cycle phase distribution. Cells were stained with Annexin-V-FITC and PI and analyzed after 48 h 
treatment with tryptanthrin. As shown in Figure 6, tryptanthrin arrested K562 cells in G0/G1 phase. The 
proportion of S phase cells in the control and 0.5% DMSO groups was relatively high, suggesting the 
K562 cells were highly proliferative. After tryptanthrin treatment, the proportion of S phase cells in 
each tryptanthrin-treated group was markedly decreased compared with the control group. We also 
found the proliferation-inhibiting effect of tryptanthrin was maximal at the dose of 25 μg/mL (S phase 
proportion 33.2% ±  2.3% vs. 46.7% ±  2.0% in the control group, P < 0.01). Compared with the control 
group, the cell populations of tryptanthrin-treated groups in the G0/G1 phase significantly increased to 
52.5% ±  3.6% (P < 0.05). These results suggested that the breakdown of DNA synthesis resulted in Int. J. Mol. Sci. 2011, 12                         
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cell killing and the breakdown was caused due to cell cycle arrest. There was no significant change in 
the G2/M phase after tryptanthrin exposure. 
Figure 6. Cell cycle distribution analysis after tryptanthrin exposure. The proportions of 
G0/G1,  S  and  G2/M  phase  cells  were  measured  by  Modfit  3.0  program.  *  P  <  0.05,   
# P < 0.01. 
 
3.6. Changes in Mitochondrial Membrane Potentials 
Tryptanthrin treated cells were examined for fluorescence density after Rhodamine 123 staining. 
The drop in the red fluorescence, suggesting the disruption of MMP,  was detected by FCM. The 
MMPs in each tryptanthrin-treated group were significantly lower than in the control and 0.5% DMSO 
groups.  And  the  reduction  of  MMP  in  the  tryptanthrin-treated  groups  was  in  parallel  with  the 
tryptanthrin concentrations (Figure 7). 
Figure 7. Induction of K562 cell mitochondrial membrane collapse in the presence of 
tryptanthrin. Mitochondrial membrane potential was assessed by FCM after Rhodamine 
123 staining. Rhodamine 123 enriched mainly in mitochondria showing red fluorescence 
reflecting  changes  of  mitochondrial  membrane  potential.  Cells  were  treated  with  no 
tryptanthrin (A), 0.5% DMSO (B) and 6.25, 12.5 and 25μg/mL tryptanthrin, respectively 
(C, D and E). 
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3.7. Expression of Bcl-2, Bax, Cyt-c and Caspase-3 
To further provide insight into tryptanthrin-induced cell apoptosis, we determined the Bcl-2, Bax, 
cytosol and mitochondrial cyt-c, pro-caspase-3 and activated caspase-3 expression 48 h after tryptanthrin 
exposure. As shown in Figure 8, Bcl-2 protein was highly expressed while Bax protein was relatively 
minimally detected in the control and 0.5% DMSO groups. The Bcl-2/Bax ratio was relatively high in 
the two groups.  However, the content of  Bcl-2 decreased  whereas Bax increased  significantly after 
tryptanthrin exposure. The Bcl-2/Bax ratio was reversed in each tryptanthrin-treated group. 
Figure 8. Western blot assay of Bcl-2, Bax and β-actin protein expression in K562 cells.   
(A)  expression  of  Bcl-2  and  Bax  after  tryptanthrin  exposure.  β-actin  was  used   
for  normalization  and  verification  of  protein  loading;  (B)  the  Bcl-2/Bax  ratio   
in  the  control,  0.5%  DMSO  and  each  tryptanthrin-treated  groups.  Lane  1:  control;   
lane 2: 0.5% DMSO; lane 3: 6.25 μg/mL tryptanthrin; lane 4: 12.5 μg/mL tryptanthrin;   
lane 5: 25 μg/mL tryptanthrin.   
 
Cyt-c can activate the pro-caspases when released from mitochondria into the cytoplasm and it is 
responsible for apoptosis through interaction with protease-activating factors. Normally, the permeability 
of the mitochondrial membrane was quite low. Cyt-c was confined in the mitochondria and defended 
from leaking into cytosolic fractions. Therefore, caspases existed in the form of pro-caspases in normal 
cells. As shown in Figure 9, the expressions of cytosol cyt-c in the control and 0.5% DMSO groups were 
very low, whereas mito cyt-c was relatively high. However, as demonstrated above, tryptanthrin could 
reduce the MMPs and increase the mitochondrial membrane permeability. Therefore, tryptanthrin led to 
increased mito cyt-c leakage and elevate cytosol cyt-c contents.   
Caspase activation is initiated by cytosol cyt-c. As shown in Figure 10A, tryptanthrin was capable 
of inducing activation and cleavage of pro-caspase-3 in vitro, upon elevated mito cyt-c leakage. We 
observed the content of pro-caspase-3 significantly decreased after tryptanthrin administration. We 
then  evaluated  the  expression  of  activated  caspase-3  subunits  p20  and  p17.  Immunoblotting  of 
activated caspase-3 using a specific monoantibody against caspase-3 revealed no detectable p20 and 
p17 found in the control and 0.5% DMSO groups. Tryptanthrin administration significantly increased 
the  content  of  p20  and  p17  in  a  dose-dependent  manner.  As  illustrated  in  Figure  10B,  addition   
of  20 μmol/L  ZVAD-FMK  (a  pan-caspase  inhibitor)  significantly  inhibited  the  activation  of 
pro-caspase-3 in response to tryptanthrin exposure.   Int. J. Mol. Sci. 2011, 12                         
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Figure 9. Western blot assay of cytosol cyt-c and mito cyt-c in K562 cells. β-actin was used 
as an internal control. The expressions of cytosol cyt-c were very low in the control and 
0.5% DMSO group. Tryptanthrin administration could lead to mito cyt-c leakage into the 
cytoplasm and increase  cytosol contents in  a dose  dependent  manner.  Lane  1:  control;   
lane 2: 0.5%DMSO; lane 3: 6.25 μg/mL tryptanthrin; lane 4: 12.5 μg/mL tryptanthrin; 
lane 5: 25 μg/mL tryptanthrin. 
 
Figure 10. Western blot assay of pro-caspase-3 and activated caspase-3 in K562 cells. 
β-actin was used as an internal control. Caspase-3 exists as its inactive form pro-caspase-3 
and there are no detectable active caspase-3 subunits in K562 cells. Administration of 
tryptanthrin induces  mito  cyt-c leakage  and  activates  pro-caspase-3. The expression of 
active  caspase-3  subunits  p20  and  p17  were  remarkably  elevated  while  pro-caspase-3 
contents  decreased  after  tryptanthrin  exposure.  However,  addition  of  a  pan-caspase 
inhibitor ZVAD-FMK significantly attenuated the pro-caspase-3 activation in response to 
tryptanthrin.  The  contents  of  p20  and  p17  remarkably  decreased  in  the  presence  of 
ZVAD-FMK. (A) Lane 1: control; lane 2: 0.5%DMSO; lane 3: 6.25 μg/mL tryptanthrin; 
lane  4:  12.5  μg/mL  tryptanthrin;  lane  5:  25  μg/mL  tryptanthrin;  (B)  Lane  1:  control;   
lane  2:  ZVAD-FMK;  lane  3:  ZVAD-FMK + 6.25  μg/mL  tryptanthrin;  lane  4: 
ZVAD-FMK + 12.5 μg/mL tryptanthrin; lane 5: ZVAD-FMK + 25 μg/mL tryptanthrin. 
 
4. Discussion 
Cancer chemoprevention is defined as inhibition of tumor initiation, promotion and progression by 
employing pharmacologic or natural agents that prevent the metabolic activation of procarcinogens. A 
number of natural phytochemicals are shown to have anti-cancer properties [15]. Their mechanisms 
responsible for executing the anti-proliferative effects mainly include blockade of tumor cell expansion 
and induction of tumor cell differentiation or apoptosis. K562 cells are derived from human CML and 
express the bcr/abl kinase. bcr/abl kinase enables the CML cells to growth in a uncontrolled way by 
inducing p38 MAPK, Ras, Jun, PI-3K/Akt and STAT5 pathways, and blockage of bcr/abl kinase by Int. J. Mol. Sci. 2011, 12                         
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imatinib  mesylate  has  been  recognized  as  the  target  therapy  for  CML  [2,16–18].  Gangemi  et  al. 
showed that bcr/abl exerted its anti-apoptotic effect against diverse apoptotic stimuli through blockage 
of mitochondrial release of cyt-c and activation of pro-caspase-3, the molecular bases of the delayed 
response of K562 cells resided downstream of Bcl-2 phosphorylation [19,20]. 
Tryptanthrin is extracted from medical herbs Polygonum tinctorium and a number of studies have 
demonstrated the application of the herbal extracts exert abundant benefits in the management of many 
disorders [6,21]. As the bioactive ingredient of the medical herbs, tryptanthrin has been reported to 
show various biological activities, including anti-microorganisms and anti-inflammation [10,11,22]. 
Recently, it was found tryptanthrin suppresses growth and proliferation of transformed or malignant 
cells through induction of apoptosis on various kinds of solid tumors by inhibiting NO synthases (NOS) 
and  cyclooxygenase  (COX)  activity  [10].  Yu  et  al.  reported  tryptanthrin  alleviates  multiple  drugs 
resistance  (MDR)  and  improves  doxorubicin  sensitivity  in  breast  cancer  cells  [13].  However,   
whether tryptanthrin has similar effects on CML and the underlying mechanisms remained unclear.   
The  primary  aim  of  the  present  study  was  to  investigate  the  proliferation-attenuating  and 
apoptosis-inducing effects of tryptanthrin on CML K562 cells through screening the best inducer and 
then proving its machinery. 
In our experiments, we showed that tryptanthrin produced a growth suppression effect on K562 
cells  in  a  time-  and  dose-dependent  manner.  Trytpanthrin  led  to  50%  decrease  in  K562  cell 
proliferation at the dosage of 8.8 μg/mL after 48 h treatment. The K562 cells undergoing apoptosis are 
evidenced by morphological changes observed under fluorescent microscopy and transmission election 
microscopy. Nuclear fragmentation and chromosome margination were clearly observed in the CTX 
and tryptanthrin-treated groups. Consistent with the observation, our flow cytometry analysis showed 
tryptanthrin at the concentrations of 6.25, 12.5 and 25μg/mL caused 21.9% ±  2.3%, 33.4% ±  3.9% and 
52.2% ±  4.7% cells in the late apoptotic zone bound (marked as PI+AV+) respectively. These results 
indicate that tryptanthrin exerts apoptosis-inducing effect as CTX does. Cell cycle distribution analysis 
showed that tryptanthrin inhibited proliferation via blocking cell cycle progression at the G0/G1 phase 
and  subsequently  progressing  into  apoptosis.  There  was  a  significant  increase  in  G0/G1  phase 
proportion and a remarkable decrease in S phase proportion in the presence of 12.5 and 25 μg/mL 
tryptanthrin compared with the control group.   
Tryptanthrin regulates cell survival and apoptosis through a phosphorylation cascade that primarily 
alters the function of transcription factors that regulate pro-apoptotic and anti-apoptotic genes. Since 
Bcl-2, a potent anti-apoptotic regulatory protein, is believed to be a crucial mediator downstream of 
apoptotic signaling, we also assessed the effect of tryptanthrin on the expression of Bcl-2. Our study 
showed that Bcl-2 was highly expressed in K562 cells. The contents of Bcl-2 decreased while Bax   
(a potent pro-apoptotic regulatory protein) was elevated in K562 cells with increasing concentrations 
of tryptanthrin. The Bcl-2/Bax ratio significantly decreased in the presence of tryptanthrin. 
Studies have revealed numerous proteins (such as COX and NOS) and cytokines (such as LT and 
IFN-γ)  were  targeted  by  tryptanthrin  [11,22,23].  Because  these  proteins  and  cytokines  were 
over-expressed during inflammation and carcinogenesis and mitochondrial damage plays a critical role 
in these processes, we investigated whether the apoptosis-inducing effect of tryptanthrin was through 
affecting  mitochondrial function.  The  underlying  events relevant  to mitochondria  were  studied  by 
measuring MMP. As expected, we observed a decline in MMP in the presence of tryptanthrin. The Int. J. Mol. Sci. 2011, 12                         
 
3843 
decline in MMP would lead to decreased ATP production and over-generation of oxidant, which is an 
early event in tryptanthrin-induced K562 cell apoptosis. Previous studies have also demonstrated that 
mitochondria are essential in the activation or amplification of the caspase cascade via the release of 
cyt-c from the mitochondrial intermembrane space [8]. Activation of the caspase cascade is considered 
as a critical sign that initiates the irreversible events in cell death. Cytosolic cyt-c is highly responsible 
for the activation of pro-caspase-3 [24]. Fei and colleagues extracted rutaecarpine (an agent having 
similar structural with tryptanthrin) from the Chinese medicinal plant Evodia rutaecarpa, and reported 
it can induce Hela cell apoptosis through cyt-c releasing [25]. In agreement with Fei’s report, our result 
here  indicated  that  tryptanthrin-induced  apoptosis  is  associated  with  mito  cyt-c  leakage,  which  is 
consistent with the activation of pro-caspase-3. Cytosolic cyt-c and active caspase-3 expressed in K562 
cells  in  a  low  level.  However,  both  cytosolic  cyt-c  and  active  caspase-3  (p20  and  p17  subunits) 
contents were elevated in response to tryptanthrin administration. The contents of cytosolic cyt-c and 
activated caspase-3 subunits were in parallel with the tryptanthrin concentrations. The expressions of 
active caspase-3 subunits p20 and p17 were significantly abolished in the presence of a pan-caspase 
inhibitor ZVAD-FMK. Therefore, it is reasonable to believe that tryptanthrin might induce K562 cell 
apoptosis by the damage of mitochondrial membrane and the cyt-c-caspase-3 dependent mechanisms. 
5. Conclusions 
In  summary,  the  present  study  highlights  that  tryptanthrin  has  proliferation-attenuating  and 
apoptosis-inducing  effects  on  the  CML  K562  cell  line  in  vitro.  Tryptanthrin  triggers  apoptosis 
associated mitochondrial breach. Disturbance of Bcl-2/Bax expression levels might participate in the 
apoptotic process and the underlying mechanisms might be cyt-c-caspase-3 dependent. Although we 
did not observe a better therapeutic effect of tryptanthrin than CTX in our study, tryptanthrin is free of 
adverse effect. Therefore, tryptanthrin might be a new candidate in the therapeutic strategy of CML. 
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